Arcutis Biotherapeutics, Inc. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001787306-25-000124
- Form type
- 10-Q
- CIK
- 0001787306
- Primary document
- https://www.sec.gov/Archives/edgar/data/1787306/000178730625000124/arqt-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arcutis Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $147.3M | - | - |
| Cost Of Revenue | $16.3M | - | - |
| Operating Income | $-39.1M | - | - |
| Net Income | $-40.9M | - | - |
| Eps Basic | -0.32 | - | - |
| Eps Diluted | -0.32 | - | - |
| Cash And Equivalents | $72.7M | - | - |
| Total Assets | $352.4M | - | - |
| Total Liabilities | $213.5M | - | - |
| Shareholders Equity | $139.0M | - | - |
| Operating Cash Flow | $-30.1M | - | - |
| Capital Expenditures | $686,000 | - | - |